Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials-Reference-Cited by-同舟云学术

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

Published:2019-07-01 Issue:7 Volume:5 Page:1008
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Wang Yucai¹²,Zhou Shouhao³⁴,Yang Fang⁵⁶,Qi Xinyue⁷,Wang Xin⁵,Guan Xiaoxiang⁵⁸,Shen Chan⁷,Duma Narjust¹²,Vera Aguilera Jesus¹²,Chintakuntlawar Ashish²,Price Katharine A.²,Molina Julian R.²,Pagliaro Lance C.²,Halfdanarson Thorvardur R.²,Grothey Axel²⁹,Markovic Svetomir N.²,Nowakowski Grzegorz S.¹,Ansell Stephen M.¹,Wang Michael L.¹⁰

Affiliation:

1. Division of Hematology, Mayo Clinic, Rochester, Minnesota

2. Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston

4. Department of Public Health Sciences, Pennsylvania State College of Medicine, Hershey

5. Medical School of Nanjing University, Nanjing, China

6. The Comprehensive Cancer Centre of Drum Tower Hospital, Clinical Cancer Institute of Nanjing University, Nanjing, China

7. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston

8. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

9. West Cancer Center, The University of Tennessee, Memphis

10. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/7/1008/17712458/jamaoncology_wang_2019_oi_190016.pdf

Reference138 articles.

1. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy.;Li;J Hematol Oncol,2018

2. Anti-PD-1 and anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations.;Seidel;Front Oncol,2018

4. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper).;Gelman;Bayesian Anal,2006

5. A weakly informative default prior distribution for logistic and other regression models.;Gelman;Ann Appl Stat,2008

Cited by 597 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Current Gene Therapy;2025-02

2. Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma;Immuno-Oncology and Technology;2024-12

3. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions;Cancer Letters;2024-11

4. Public Preference for Off-Label Use of Drugs for Cancer Treatment and Relative Importance of Associated Adverse Events: A Discrete Choice Experiment and Best-Worst Scaling;Applied Health Economics and Health Policy;2024-09-10

5. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09